Trial finds over-the-counter nasal sprays could reduce RTIs and antibiotic use
Affecting parts of the body involving breathing, RTIs impact one in five people in England
Read More
Tag: University of Southampton
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
